A Delaware court has dismissed a lawsuit filed by David Rostov against Alcon Research, LLC, and several other parties. The ruling, issued on June 26, 2026, under docket number C.A. No. 2025-0648-KSJM, addresses claims related to corporate governance and shareholder rights within Aurion Biotech, Inc., a company involved in ongoing litigation over its management and strategic direction.
The lawsuit arose from a series of disputes between rival stockholders of Aurion Biotech, primarily between Alcon Research and Deerfield Private Design Fund. Rostov, a former CFO and stockholder of Aurion, claimed that the actions taken by Alcon and its affiliates harmed the company and its shareholders by obstructing a potential initial public offering (IPO). This case is significant as it highlights the complexities of shareholder rights and corporate governance in the context of competing interests among investors.
Background
David Rostov, the plaintiff, was a stockholder in Aurion Biotech, which has been embroiled in litigation involving its stockholders, particularly Alcon Research and Deerfield. Both Alcon and Deerfield participated in a 2022 Series C funding round, acquiring significant shares of the company. In this funding round, Alcon secured a voting agreement that allowed it to appoint members to Aurion's board of directors, which created a power struggle with Deerfield.
As the disputes escalated, Alcon sought to explore acquiring Aurion and initiated a special committee to evaluate this option. However, the committee ultimately decided to pursue an IPO, a move that Alcon opposed. This led to a series of actions taken by Alcon that Rostov claims were detrimental to Aurion's interests and violated fiduciary duties. The case reached the Delaware Court of Chancery after various related lawsuits were filed, including claims against Alcon for allegedly blocking the IPO.
The Ruling
The court ruled in favor of the defendants, granting their motion to dismiss Rostov's complaint. Chancellor Kathaleen St. J. McCormick stated, "The Controller Claim is dismissed" and noted that Rostov's allegations did not sufficiently demonstrate that Alcon and its affiliates acted in bad faith or breached their fiduciary duties. The court emphasized that Rostov failed to provide adequate evidence that the decisions made by the board of directors were not in the best interests of the company.
In dismissing the claims, the court highlighted that the decision to postpone the IPO was made by a special committee before Alcon became the controlling stockholder. The court found that Rostov's claims were based on assumptions about the company's future actions rather than concrete evidence of wrongdoing. The ruling effectively shields Alcon and its affiliates from liability for the decisions made regarding the IPO and the company's governance.
Impact
The dismissal of this lawsuit has significant implications for corporate governance and shareholder rights. It reinforces the principle that corporate boards are presumed to act in good faith and that minority shareholders must provide compelling evidence to challenge board decisions. The ruling may discourage similar lawsuits from minority shareholders who believe that corporate actions are not in their best interests, as the court's decision underscores the high threshold for proving breaches of fiduciary duty.
Furthermore, this case illustrates the challenges that shareholders face when navigating disputes within companies, especially when competing interests among major investors are at play. The outcome may influence how companies structure their governance and decision-making processes in the future, particularly in situations involving multiple significant shareholders.
What's Next
Following this ruling, Rostov and other shareholders may consider their options for appeal, although the court's decision provides a strong legal foundation for the defendants. There are no related cases pending that directly address the issues raised in this lawsuit, but the ongoing dynamics within Aurion Biotech and its shareholders may lead to further disputes in the future.